期刊文献+

Fas与FasL在人类同种异体移植肾组织中的表达及意义 被引量:3

THE INCREASE OF RENAL FAS AND FAS L EXPRESSION IS ASSOCIATED WITH RENAL ALLOGRAFT REJECTION
暂未订购
导出
摘要 目的:研究Fas与FasL在人类同种异体移植肾组织中的表达,探讨其在人类同种异体肾移植排斥反应中的作用。方法:用免疫组织化学方法对30例人类同种异体肾移植切除标本中Fas与FasL的表达进行检测。结果:急性排斥反应的肾组织中FasL的表达强度显著高于慢性排斥反应肾组织(P<0.05)。FasL的表达强度与急性排斥反应的严重程度呈正相关。Fas在急、慢性排斥反应中均有较强的表达,但两组差异不显著。结论:FasL与急性排斥反应有关,其表达强度与急性排斥反应的严重程度呈正相关。Fas可能参与排斥反应。 OBJECTIVE To define the association of renal Fas and FasL expression with renal allograft rejection METHODOLOGY Renal tissues were obtained from 17 patients with acute and 13 patients with chronic allograft rejection. Renal histology was examined and recorded based on the Banff scoring system. Immunostaining was performed using anti Fas and anti FasL antibodies. The intensity of staining was graded on a 0 to 4+ scale. RESULTS There was a significant increase of the staining of Fas and FasL in tissues from both acute and chronic renal allograft rejection. Although the staining pattern was similar in acute and chronic allograft rejection, the scale of FasL staining was higher in tissues from acute renal allograft rejection than in tissues from chronic renal allograft rejection than in tissues from chronic allograft rejection, and the scale was correlated with the severity of the acute renal injury. CONCLUSION The increase of Fas and FasL in renal tissue from patients with both acute and chronic allograft rejection indicates that these two molecules are involved in the process of allograft rejection.
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 1998年第4期320-322,共3页 Chinese Journal of Nephrology,Dialysis & Transplantation
基金 北京市青年科技骨干培养基金
关键词 肾移植 排斥反应 FAS/FASL Fas/FasL renal allograft rejection
  • 相关文献

同被引文献14

  • 1傅西林 刘复生 等.乳腺恶性肿瘤.肿瘤病理学[M].北京:北京医科大学中国协和医科大学联合出版社,1997.1627-1662.
  • 2夏成青,肾脏病与透析肾脏移植杂志,1998年,7卷,320页
  • 3傅西林,肿瘤病理学,1997年,1627页
  • 4Mountz J B,Clin Immunol Immunopathol,1996年,80卷,2页
  • 5Nagata S, Golstein P. The Fas death factor [J].Sciene, 1995,267:1449-1456.
  • 6Perianyagam MC, Murray SL, Balakinshnan VS, et al. Seurm soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure [J]. Lab Clin Med, 2000,136:320.
  • 7Masashi S, Takako K, Naoki Y, et al. Fas-Fas ligand system in the peripheral blood of patients with renal disease [J]. Nephron,2000,85:107-113.
  • 8Suda T, Hashimoto H, Tanaka M, et al. Membrane Fas ligand kill human peripheral blood T lymphocytes and soluble Faslig and blocks the killing [J]. Exp Med, 1997,186:2045-2050.
  • 9Shima Y, Nishimoto N, Ogata A, et al. Myeloma cells express Fas antigen/APO-1(CD95) bet only some are senitive to anti-Fas antibody resulting in apoptosis[J]. Blood,1998,85:757 ~ 764.
  • 10Nambu Y, Hughes SJ, et al. Lack of cell surface Fas/APO-1 experssion in pulmonary adenocarcinomas[ J]. J Clin Invest, 1998,101 (5): 1102 ~ 1110.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部